Literature DB >> 16463412

Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.

Dan Caspi1, Marina Anouk, Itzhak Golan, Daphna Paran, Ilana Kaufman, Irena Wigler, David Levartovsky, Irena Litinsky, Ori Elkayam.   

Abstract

OBJECTIVE: To assess the levels of anti-cyclic citrullinated peptide (anti-CCP) and IgA rheumatoid factor (IgA-RF) in synovial fluids of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and osteoarthritis (OA).
METHODS: Knee effusions of 29 patients with RA (23 women, 6 men; mean +/- SD age 60 +/- 15 years), 20 with PsA (6 women, 14 men; mean age 51 +/- 12 years), and 19 with OA (9 women, 10 men; mean age 73 +/- 11.8 years) were aspirated, tested for white blood cell (WBC) counts, centrifuged, and stored at -20 degrees . Sera of 22, 11, and 12 of these patients with RA, PsA, and OA, respectively, were similarly stored. IgG anti-CCP and IgA-RF were detected by enzyme-linked immunosorbent assay. Erythrocyte sedimentation rate and C-reactive protein levels were used as measures of disease activity.
RESULTS: Mean levels of synovial fluid anti-CCP and IgA-RF were significantly increased in RA joint effusions compared with PsA and OA (anti-CCP: 150 +/- 134, 34 +/- 29, and 24 +/- 26 units, respectively [P < 0.003]; IgA-RF: 76 +/- 77, 15.7 +/- 10, and 18 +/- 20 units, respectively). No significant difference was noted between OA and PsA. A significant correlation was found between synovial fluid anti-CCP and serum anti-CCP and IgA-RF. In patients with RA, a significant correlation was found between synovial fluid WBC counts and IgA-RF (P = 0.03) and serum IgA-RF (P = 0.008), but not between synovial fluid and serum anti-CCP levels. In RA patients, C-reactive protein correlated with serum IgA-RF.
CONCLUSION: Anti-CCP and IgA-RF were significantly increased in synovial fluid of RA in comparison with PsA and OA patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463412     DOI: 10.1002/art.21691

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.

Authors:  Dalila Mrabet; Lilia Laadhar; Héla Sahli; Béchir Zouari; Slim Haouet; Houria Lahmar; Sondes Makni; Slaheddine Sellami
Journal:  Clin Rheumatol       Date:  2011-09-28       Impact factor: 2.980

2.  The expression of PADI4 in synovium of rheumatoid arthritis.

Authors:  Xiaotian Chang; Yan Zhao; Shui Sun; Yunzhong Zhang; Youming Zhu
Journal:  Rheumatol Int       Date:  2009-02-08       Impact factor: 2.631

3.  Anticitrullinated protein/peptide antibodies in rheumatoid arthritis.

Authors:  Wolfgang L Gross; Frank Moosig; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

Review 4.  Of mice and men: how animal models advance our understanding of T-cell function in RA.

Authors:  Tamás Kobezda; Sheida Ghassemi-Nejad; Katalin Mikecz; Tibor T Glant; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-01-07       Impact factor: 20.543

5.  Anomalies of intra-synovial citrullination: is there any interest in the diagnosis of early rheumatoid arthritis?

Authors:  Dalila Mrabet; Lilia Laadhar; Slim Haouet; Héla Sahli; Béchir Zouari; Sondès Makni; Slaheddine Sellami
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

6.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

7.  Correlation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients.

Authors:  Hyun Hee Kim; Jihun Kim; Sung-Hoon Park; Seong-Kyu Kim; Ok-Dong Kim; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

8.  Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.

Authors:  Michelle L Harris; Erika Darrah; Gordon K Lam; Susan J Bartlett; Jon T Giles; Audrey V Grant; Peisong Gao; William W Scott; Hani El-Gabalawy; Livia Casciola-Rosen; Kathleen C Barnes; Joan M Bathon; Antony Rosen
Journal:  Arthritis Rheum       Date:  2008-07

9.  Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.

Authors:  Frances Humby; Michele Bombardieri; Antonio Manzo; Stephen Kelly; Mark C Blades; Bruce Kirkham; Jo Spencer; Costantino Pitzalis
Journal:  PLoS Med       Date:  2009-01-13       Impact factor: 11.069

10.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.